A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma

There are no reports of blood triglyceride (TG) levels increasing with the ABVD regimen. Herein, we present a case of Hodgkin's lymphoma that exhibited ABVD-induced blood TG increase. The patient was a 40-year-old Japanese man. Empiric therapy was initiated using the ABVD regimen for Hodgkin ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Yonezawa, Ryo, Shimamoto, Kazushi, Kabasawa, Nobuyuki, Sano, Mizuki, Tanaka, Shizuko, Matsui, Mitsuki, Harada, Hiroshi, Sunaga, Tomiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023944/
https://www.ncbi.nlm.nih.gov/pubmed/36941843
http://dx.doi.org/10.1016/j.lrr.2023.100365
Descripción
Sumario:There are no reports of blood triglyceride (TG) levels increasing with the ABVD regimen. Herein, we present a case of Hodgkin's lymphoma that exhibited ABVD-induced blood TG increase. The patient was a 40-year-old Japanese man. Empiric therapy was initiated using the ABVD regimen for Hodgkin lymphoma. On day 58, the fasting blood TG concentration increased to 1,451 mg/dL. Since no adverse events were noted, 0.2 mg/day of pemafibrate was administered, and the ABVD regimen was continued. Blood TG levels should be periodically monitored during ABVD administration for the patients who are at high risk of increased blood TG levels.

Ejemplares similares